Fluorescence properties of retinoid X receptor antagonist NEt-SB

Competitive Binding Assay with an Umbelliferone-Based Fluorescent Rexinoid for Retinoid X Receptor Ligand Screening

(2019) Shoya Yamada et al.   JOURNAL OF MEDICINAL CHEMISTRY

Emerging roles of bexarotene in the prevention, treatment and anti-drug resistance of cancers

(2018) Danyang Shen et al.   Expert Review of Anticancer Therapy

Bexarotene Modulates Retinoid-X-Receptor Expression and Is Protective Against Neurotoxic Endoplasmic Reticulum Stress Response and Apoptotic Pathway Activation

(2018) Yogita Dheer et al.   MOLECULAR NEUROBIOLOGY

Nuclear Receptors, RXR, and the Big Bang

(2014) Ronald M. Evans et al.   CELL

Low Dose Bexarotene Treatment Rescues Dopamine Neurons and Restores Behavioral Function in Models of Parkinson’s Disease

(2013) Krista McFarland et al.   ACS Chemical Neuroscience

ApoE-Directed Therapeutics Rapidly Clear  -Amyloid and Reverse Deficits in AD Mouse Models

(2012) P. E. Cramer et al.   SCIENCE

Discovery of a Potent Retinoid X Receptor Antagonist Structurally Closely Related to RXR Agonist NEt-3IB

(2011) Mariko Nakayama et al.   ACS Medicinal Chemistry Letters

Activation of Retinoid X Receptor increases dopamine cell survival in models for Parkinson's disease

(2009) Stina Friling et al.   BMC NEUROSCIENCE

Bexarotene Induces Dyslipidemia by Increased Very Low-Density Lipoprotein Production and Cholesteryl Ester Transfer Protein-Mediated Reduction of High-Density Lipoprotein

(2009) Jitske de Vries-van der Weij et al.   ENDOCRINOLOGY

Physical Properties (Density, Excess Molar Volume, Viscosity, Surface Tension, and Refractive Index) of Ethanol + Glycerol

(2008) Abdullah S. Alkindi et al.   JOURNAL OF CHEMICAL AND ENGINEERING DATA